跳至主要内容
临床试验/CTRI/2024/08/071886
CTRI/2024/08/071886尚未招募不适用

Postoperative quality of recovery after hysterectomy in patient on Duloxetine

Kasturba Medical College1 个研究点 分布在 1 个国家目标入组 62 人开始时间: 2024年8月15日最近更新:

试验速览

阶段
不适用
状态
尚未招募
入组人数
62
试验地点
1
主要终点
1. Quality of Recovery-40

研究概览

简要总结

Postoperative pain is one of the main issues in postoperative care and plays an important role

in accelerating the improvement of surgical patient’s general condition 1 . Female patients have

worse quality of recovery after surgery than male patients. The greater propensity for pain

and opioid-related side effects are likely contributing factors for poor postsurgical recovery in

women. Hysterectomy is a commonly performed surgical procedure in women, and it often

results in significant pain and slow recovery 2 . One of the strategies to prevent chronic

postoperative pain is to reduce the acute pain in the initial phase using effective medications

with the least side effects. Nevertheless, pharmacologic strategies to improve global quality

of recovery after hysterectomy have yet to be examined 2 .

In this study, we intended to evaluate the effect of perioperative administration of oral

Duloxetine on postoperative pain and recovery in patients undergoing hysterectomy.

Duloxetine is a selective serotonin and norepinephrine reuptake inhibitor (SNRI) commonly

used to treat depression, anxiety and chronic pain. The medication works by increasing the

levels of serotonin and norepinephrine in the brain, which can help to reduce pain, improve

mood and promote relaxation. Duloxetine has also been found to have a mild analgesic effect

and has been investigated as a premedication for various surgical procedures, including

hysterectomy. Duloxetine premedication in hysterectomy effectively reduces pain and

improves patient satisfaction. Duloxetine has been shown to improve the quality of

anaesthesia, reduce the need for additional pain medication and cause lesser adverse events

when compared to those who do not receive premedication.

This study aims to investigate the efficacy and safety of perioperative oral Duloxetine on

quality of recovery and as an analgesia in adult patients undergoing hysterectomy and the

Quality of Recovery-40 questionnaire (QoR-40) shall be used for evaluation.

研究设计

研究类型
Interventional
分配方式
Na
盲法
None

入排标准

年龄范围
18.00 Year(s) 至 70.00 Year(s)(—)
性别
Female

入选标准

  • Patients with benign gynaecologic conditions (fibroids, pelvic pain, uterine prolapse) who are planned to undergo hysterectomy under spinal anaesthesia.
  • Female patients older than 18 years with ASA I or II.

排除标准

  • Patients with chronic non-gynaecologic conditions (liver or pulmonary disease, diabetes mellitus)
  • The history of use of psychotropic drugs (anti-depressants, neuroleptics, lithium) in the last 1 year.
  • Those with Duloxetine allergy.
  • Patients using opioids for gynaecologic or non-gynaecologic conditions.

结局指标

主要结局

1. Quality of Recovery-40

时间窗: Both the respective Groups will be assessed Postoperatively at 6th, 12th and 24th hours after the surgery.

questionnaire total score

时间窗: Both the respective Groups will be assessed Postoperatively at 6th, 12th and 24th hours after the surgery.

2. Visual Analogue score

时间窗: Both the respective Groups will be assessed Postoperatively at 6th, 12th and 24th hours after the surgery.

次要结局

  • 1. Opioid analgesic consumption(doses (Fentanyl))

研究者

申办方类型
Private medical college
责任方
Principal Investigator
主要研究者

Dr Kashmla Khan

Kasturba Medical College, Mangalore

研究点 (1)

Loading locations...

相似试验